V Wealth Advisors LLC Ironwood Pharmaceuticals Inc Transaction History

V Wealth Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 16, 2019	SELL	$8.27 - $12.73 $100,538 - $154,758	-12,157 Closed	0 $0
Q3 2018 Oct 31, 2018	SELL	$14.31 - $17.65 $19,204 - $23,686	-1,342 Reduced 9.94%	12,157 $224,000
Q2 2018 Jul 16, 2018	BUY	$11.83 - $16.2 $159,693 - $218,683	13,499 New	13,499 $258,000
Q4 2017 Jan 19, 2018	SELL	$12.16 - $14.58 $201,564 - $241,678	-16,576 Closed	0 $0
Q3 2017 Oct 12, 2017	BUY	$12.07 - $14.87 $200,072 - $246,485	16,576	16,576 $269,000

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $562M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of V Wealth Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on V Wealth Advisors LLC with notifications on news.